CORONAVIRUS/Taiwan’s COVID-19 vaccine could begin human trials this fall: VP

Focus Taiwan
Date: 05/22/2020
By: Wen Kuei-hsiang and Elizabeth Hsu

Vice President Lai Ching-te (center)/Image from Lai’s FB page at www.facebook.com/chingte

Taipei, May 22 (CNA) A vaccine Taiwan's National Health Research Institutes (NHRI) is developing for the novel coronavirus disease (COVID-19) will enter human trials as early as this autumn, Vice President Lai Ching-te (賴清德) disclosed Friday.

Lai made the announcement in a Facebook post after visiting the NHRI's Animal Biological Safety Level 3 (ABSL-3) laboratory in Chunan in Miaoli County to see how work on a vaccine was progressing.

In April, NHRI President Liang Kung-yee (梁賡義) revealed that a COVID-19 vaccine being developed by the national health research institution had produced promising results in mice.

The NHRI has been working on developing four kinds of vaccines against COVID-19 since February, with the development of a peptide vaccine progressing the fastest, Liang told CNA.    [FULL  STORY]

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.